Have A Question?
Contact us
UK Ireland
T: 44 (0) 1707 37 22 11
E:info@analytiqa.com
T: 353 (0) 16 40 18 18
E:info@analytiqa.com
#

Sanofi appoints Executive Vice President, Group Chief Medical Officer 10 March 2016

Responsible for enterprise-wide medical, patient safety, medical quality assurance

Sanofi has announced the appointment of Dr. Ameet Nathwani as a new member of the Executive Committee, effective May 1, 2016. Dr. Nathwani joins Sanofi from Novartis and will take the position of Executive Vice President, Group Chief Medical Officer.

Dr. Nathwani will be responsible for enterprise-wide medical, patient safety, medical quality assurance and will insure the highest standard of transparency and compliance in Sanofi's interactions with healthcare providers, patients and medical organizations. He will work in cooperation with Global R&D and the Global Business Units. Dr. Nathwani succeeds Dr. Paul Chew who has served as Senior Vice President, Chief Medical Officer since January 2013 and plans to retire later this year.

A U.K. citizen, born in Uganda and educated in the U.K., Dr. Nathwani has more than 20 years of experience in the pharmaceutical industry beginning in 1994 when he joined Glaxo Group Research. From the period of 1994 to 2004 he held increasingly senior global functional and franchise leadership roles in research and development in Glaxo, SmithKline Beecham and GlaxoSmithKline, both in Europe and US. He joined Novartis in 2004 as the Senior Vice President and Global Development Head of the Cardiovascular and Metabolic Franchise and over the period of 11 years has held a number of senior development and commercial positions including the Global Head of the Critical Care Business Franchise. He was appointed as Global Head of Medical Affairs Novartis Pharma AG in June 2014 and became an extended member of the Pharma Executive Committee where he led the establishment of a Real World Evidence Center of Excellence and Digital Medicine capability.